Alison Bauerlein, who serves as Chief Operating Officer at Sight Sciences, Inc. (NASDAQ: SGHT), completed a transaction on July 2, 2026, selling 24,184 shares of the company’s common stock. The aggregate value of this sale reached approximately $129,626. The shares were liquidated at a weighted average price of $5.36 per share, with individual transaction prices ranging from $5.19 to $5.46. Sight Sciences states that the sale was executed specifically to cover tax liabilities associated with the vesting of restricted stock units. Following this transaction, Ms. Bauerlein directly holds 664,709 shares. This total includes 192,669 shares of common stock and 472,040 shares that represent unvested restricted stock units.
The stock currently trades at $5.48, reflecting a 30% gain over the past year. Despite this appreciation, InvestingPro analysis indicates that the company appears overvalued at current levels. The stock exhibits a beta of 2.38, signaling significant volatility relative to the broader market. Investors monitoring Sight Sciences may find the revenue growth encouraging, though the earnings per share miss highlights areas for potential improvement. These developments are crucial for stakeholders and analysts observing the company’s performance.
In other recent news, Sight Sciences reported its Q1 2026 earnings, showing a mixed financial performance. The company achieved a revenue of $19.7 million, surpassing expectations by 6.2%. However, Sight Sciences reported an earnings per share of -$0.24, which was below the forecast by 41.18%. Despite the mixed results, the stock price remained relatively stable following the announcement. Investors may find the revenue growth encouraging, though the EPS miss highlights areas for potential improvement. These recent developments are crucial for stakeholders and analysts observing the company’s performance.